Change in the Major Shareholder and Largest Shareholder among the Major Shareholders
GNI Group Ltd., BCP Asia AYM Holding (Cayman) L.P.
GNI Group Ltd. decided to issue new shares through a private placement to BCP Asia AYM Holding (Cayman) L.P., a shareholder of あゆみ製薬ホールディングス株式会社, as an in-kind contribution in connection with the acquisition of all shares of あゆみ製薬ホールディングス株式会社.
No amount stated. The change will have no impact on GNI Group Ltd.'s management structure, results of operations or other matters.
The change will have no impact on the Company's management structure, financial results or other matters.
Change in voting rights ownership ratio
The voting rights ownership percentage is the proportion of the voting rights exercisable at a shareholders' meeting held by the shareholder.
0 voting rights (0 shares), representing “—” of total voting rights held by all shareholders, as of 31 March 2026
69,820 voting rights (6,982,004 shares), representing 10.63%, ranking 1st among major shareholders. Based on 656,969 total voting rights, calculated by adding the 99,742 voting rights to be increased through the issuance of these new shares to the 557,227 total voting rights as of 31 March 2026
The change is expected to occur between 30 June 2026 and 30 September 2026 following the issuance of these new shares. The change will have no impact on GNI Group Ltd.'s management structure, results of operations or other matters.
| Item | Details |
|---|---|
| Event name | Change in the Major Shareholder and Largest Shareholder among the Major Shareholders |
| Date of occurrence | From 30 June 2026 to 30 September 2026 (scheduled date of change) |
| Subject Entity | GNI Group Ltd., BCP Asia AYM Holding (Cayman) L.P. |
| Cause | GNI Group Ltd. decided to issue new shares through a private placement to BCP Asia AYM Holding (Cayman) L.P., a shareholder of あゆみ製薬ホールディングス株式会社, as an in-kind contribution in connection with the acquisition of all shares of あゆみ製薬ホールディングス株式会社. |
| Amount of Impact on Business Performance | No amount stated. The change will have no impact on GNI Group Ltd.'s management structure, results of operations or other matters. |
| Impact on Earnings Forecast | The change will have no impact on the Company's management structure, financial results or other matters. |
| Voting rights ownership percentage before the change | 0 voting rights (0 shares), representing “—” of total voting rights held by all shareholders, as of 31 March 2026 |
| Voting rights ownership percentage after the change | 69,820 voting rights (6,982,004 shares), representing 10.63%, ranking 1st among major shareholders. Based on 656,969 total voting rights, calculated by adding the 99,742 voting rights to be increased through the issuance of these new shares to the 557,227 total voting rights as of 31 March 2026 |
| Outlook | The change is expected to occur between 30 June 2026 and 30 September 2026 following the issuance of these new shares. The change will have no impact on GNI Group Ltd.'s management structure, results of operations or other matters. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.GNI Group Ltd. will acquire all shares of あゆみ製薬ホールディングス and issue new shares through a private placement to BCP Asia AYM Holding (Cayman) L.P., a shareholder of あゆみ製薬ホールディングス, as an in-kind contribution.